239 related articles for article (PubMed ID: 17233786)
21. A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder.
White WB; Grady D; Giudice LC; Berry SM; Zborowski J; Snabes MC
Am Heart J; 2012 Jan; 163(1):27-32. PubMed ID: 22172433
[TBL] [Abstract][Full Text] [Related]
22. Validation of a Women's Sexual Interest Diagnostic Interview--Short Form (WSID-SF) and a Daily Log of Sexual Activities (DLSA) in postmenopausal women with hypoactive sexual desire disorder.
DeRogatis LR; Allgood A; Auerbach P; Eubank D; Greist J; Bharmal M; Zipfel L; Guo CY
J Sex Med; 2010 Feb; 7(2 Pt 2):917-27. PubMed ID: 19832932
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
Davis SR; van der Mooren MJ; van Lunsen RH; Lopes P; Ribot C; Rees M; Moufarege A; Rodenberg C; Buch A; Purdie DW
Menopause; 2006; 13(3):387-96. PubMed ID: 16735935
[TBL] [Abstract][Full Text] [Related]
24. Men's sexual response to female partner's intranasal oxytocin administration for hypoactive sexual desire disorder: an open prospective cohort study.
Muin DA; Sheikh Rezaei S; Tremmel-Scheinost M; Salama M; Luger A; Wolzt M; Husslein PW; Bayerle-Eder M
Fertil Steril; 2017 Mar; 107(3):781-787.e3. PubMed ID: 28189292
[TBL] [Abstract][Full Text] [Related]
25. Toward personalized sexual medicine (part 3): testosterone combined with a Serotonin1A receptor agonist increases sexual satisfaction in women with HSDD and FSAD, and dysfunctional activation of sexual inhibitory mechanisms.
van Rooij K; Poels S; Bloemers J; Goldstein I; Gerritsen J; van Ham D; van Mameren F; Chivers M; Everaerd W; Koppeschaar H; Olivier B; Tuiten A
J Sex Med; 2013 Mar; 10(3):824-37. PubMed ID: 23130675
[TBL] [Abstract][Full Text] [Related]
26. Satisfying sexual events as outcome measures in clinical trial of female sexual dysfunction.
Kingsberg SA; Althof SE
J Sex Med; 2011 Dec; 8(12):3262-70. PubMed ID: 21883949
[TBL] [Abstract][Full Text] [Related]
27. Clinically relevant changes in sexual desire, satisfying sexual activity and personal distress as measured by the profile of female sexual function, sexual activity log, and personal distress scale in postmenopausal women with hypoactive sexual desire disorder.
DeRogatis LR; Graziottin A; Bitzer J; Schmitt S; Koochaki PE; Rodenberg C
J Sex Med; 2009 Jan; 6(1):175-83. PubMed ID: 19170847
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of premenopausal and postmenopausal women with acquired, generalized hypoactive sexual desire disorder: the Hypoactive Sexual Desire Disorder Registry for women.
Rosen RC; Maserejian NN; Connor MK; Krychman ML; Brown CS; Goldstein I
Menopause; 2012 Apr; 19(4):396-405. PubMed ID: 22076307
[TBL] [Abstract][Full Text] [Related]
29. A double-blind, randomized, placebo-controlled trial of the effect of testosterone cream on the sexual motivation of menopausal hysterectomized women with hypoactive sexual desire disorder.
El-Hage G; Eden JA; Manga RZ
Climacteric; 2007 Aug; 10(4):335-43. PubMed ID: 17653960
[TBL] [Abstract][Full Text] [Related]
30. Testosterone patches for female sexual dysfunction.
Drug Ther Bull; 2009 Mar; 47(3):30-4. PubMed ID: 19261838
[TBL] [Abstract][Full Text] [Related]
31. The use of dehydroepiandrosterone in the treatment of hypoactive sexual desire disorder: a report of gender differences.
Bloch M; Meiboom H; Zaig I; Schreiber S; Abramov L
Eur Neuropsychopharmacol; 2013 Aug; 23(8):910-8. PubMed ID: 23084789
[TBL] [Abstract][Full Text] [Related]
32. Androgens and Psychosocial Factors Related to Sexual Dysfunctions in Premenopausal Women
Wåhlin-Jacobsen S; Kristensen E; Pedersen AT; Laessøe NC; Cohen AS; Hougaard DM; Lundqvist M; Giraldi A
J Sex Med; 2017 Mar; 14(3):366-379. PubMed ID: 28117267
[TBL] [Abstract][Full Text] [Related]
33. Responder Analyses from a Phase 2b Dose-Ranging Study of Bremelanotide.
Althof S; Derogatis LR; Greenberg S; Clayton AH; Jordan R; Lucas J; Spana C
J Sex Med; 2019 Aug; 16(8):1226-1235. PubMed ID: 31277966
[TBL] [Abstract][Full Text] [Related]
34. Role of testosterone in the treatment of hypoactive sexual desire disorder.
Schwenkhagen A; Studd J
Maturitas; 2009 Jun; 63(2):152-9. PubMed ID: 19359109
[TBL] [Abstract][Full Text] [Related]
35. Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial.
Goldfischer ER; Breaux J; Katz M; Kaufman J; Smith WB; Kimura T; Sand M; Pyke R
J Sex Med; 2011 Nov; 8(11):3160-72. PubMed ID: 21933348
[TBL] [Abstract][Full Text] [Related]
36. Flibanserin for Hypoactive Sexual Desire Disorder: An Open-Label Safety Study.
Simon JA; Derogatis L; Portman D; Brown L; Yuan J; Kissling R
J Sex Med; 2018 Mar; 15(3):387-395. PubMed ID: 29502984
[TBL] [Abstract][Full Text] [Related]
37. Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder: Results of the PLUMERIA Study.
Portman DJ; Brown L; Yuan J; Kissling R; Kingsberg SA
J Sex Med; 2017 Jun; 14(6):834-842. PubMed ID: 28583342
[TBL] [Abstract][Full Text] [Related]
38. Vaginal application of testosterone: A study on pharmacokinetics and the sexual response in healthy volunteers.
Apperloo M; Midden M; van der Stege J; Wouda J; Hoek A; Weijmar Schultz W
J Sex Med; 2006 May; 3(3):541-9. PubMed ID: 16681480
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of Tribulus terrestris for the treatment of hypoactive sexual desire disorder in postmenopausal women: a randomized, double-blinded, placebo-controlled trial.
de Souza KZ; Vale FB; Geber S
Menopause; 2016 Nov; 23(11):1252-1256. PubMed ID: 27760089
[TBL] [Abstract][Full Text] [Related]
40. Hypoactive sexual desire disorder in menopausal women: a survey of Western European women.
Dennerstein L; Koochaki P; Barton I; Graziottin A
J Sex Med; 2006 Mar; 3(2):212-22. PubMed ID: 16490014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
